In the TNBS mouse model of colitis, berberine reduces IFNγ, IL-1α, IL-6, IL-17, and TNFα expression in colonic tissues and sera and suppresses Th1 and Th17 cells through reduction of STAT1, STAT3, and NF-κB phosphorylation [57]. Here, IL17A is linked to colitis.